Novavax, Inc.

NVAX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$10.06-3.92%

2026-10-30

Financials

Valuation Metrics

Novavax, Inc.'s Market Cap is $1.65B. At end of 2025 it was $1.09B. Ranked #2096 of 3,116 in US market (top 67%), #808 of 1,472 on NASDAQ (top 55%), #147 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 55%) by Market Cap.

Investment Metrics(as of 2026-10-30)

Metric	Value	Rank
Size
Market Cap	$1.65B	US#2,096/3,116 Sec#147/265
Revenue	$414M	US#2,315/3,116 Sec#84/265
Net Income	$-248M	US—/3,116 Sec—/265
Total Assets	$956M	US#2,494/3,116 Sec#106/265
Net Assets	$-191M	US#2,974/3,116 Sec#255/265
Value
P/S	4.00x	US#2,104/3,116 Sec#68/265
FCF Yield	-2.64%	US—/3,116 Sec—/265
Profitability
ROA	-25.92%	US#2,852/3,116 Sec#147/265
Op. Margin	-54.94%	US#2,661/3,116 Sec#111/265
Revenue Growth	-61.64%	US#2,701/3,116 Sec#161/265
Earnings Growth	-158.59%	US#1,903/3,116 Sec#59/265
Financial Health
Total Debt	$296M	US#2,093/3,116 Sec#79/265
FCF	$-44M	US#2,506/3,116 Sec#110/265
Cash	$191M	US#1,764/3,116 Sec#112/265
Current Ratio	2.33x	US#1,051/3,116 Sec#207/265
Performance
1Y Return	19.34%	US#1,040/3,116 Sec#106/265
1M Return	-6.94%	US#2,166/3,116 Sec#150/265
From 52W High	-24.87%	US#1,624/3,116 Sec#94/265
1Y MDD	-34.58%	US#1,627/3,116 Sec#90/265
Trading
Volume	3,336,517 shares	US#699/3,116 Sec#58/265
Trading Value	$34M	US#1,693/3,116 Sec#125/265
Per Share
EPS	$-1.51	US—/3,116 Sec—/265
BPS	$-1.16	US—/3,116 Sec—/265